Hans Lennernäs
Department of Pharmacy
Uppsala University
Box 580
SE-751 23 Uppsala
Sweden
Name/email consistency: high
- In Vivo Investigation in Pigs of Intestinal Absorption, Hepatobiliary Disposition, and Metabolism of the 5{alpha}-Reductase Inhibitor Finasteride and the Effects of Coadministered Ketoconazole. Lundahl, A., Hedeland, M., Bondesson, U., Lennernäs, H. Drug Metab. Dispos. (2011)
- Biliary excretion of ximelagatran and its metabolites and the influence of erythromycin following intraintestinal administration to healthy volunteers. Matsson, E.M., Eriksson, U.G., Knutson, L., Hoffmann, K.J., Logren, U., Fridblom, P., Petri, N., Lennernäs, H. J. Clin. Pharmacol (2011)
- Ethanol-drug absorption interaction: potential for a significant effect on the plasma pharmacokinetics of ethanol vulnerable formulations. Lennernäs, H. Mol. Pharm. (2009)
- Modeling gastrointestinal drug absorption requires more in vivo biopharmaceutical data: experience from in vivo dissolution and permeability studies in humans. Lennernäs, H. Curr. Drug Metab. (2007)
- Animal data: the contributions of the Ussing Chamber and perfusion systems to predicting human oral drug delivery in vivo. Lennernäs, H. Adv. Drug Deliv. Rev. (2007)
- Intestinal permeability and its relevance for absorption and elimination. Lennernäs, H. Xenobiotica (2007)
- Clinical pharmacokinetics of atorvastatin. Lennernäs, H. Clin. Pharmacokinet (2003)